Fungal cell membrane and cell wall components

Fungal cell membranes and cell walls are essential structural components that distinguish fungi from mammalian cells, making them primary targets for selective antifungal therapy [1, 13]. The fungal plasma membrane is uniquely characterized by the presence of ergosterol, a sterol that maintains membrane fluidity and integrity, whereas the cell wall provides a rigid outer layer composed of a complex network of beta-glucans, chitin, and mannoproteins [3, 7]. These structures protect the fungus from osmotic stress and environmental hazards while facilitating vital processes such as nutrient transport and signal transduction [6, 13]. Antifungal drugs exploit these differences through various mechanisms: polyenes bind directly to ergosterol to form lethal pores; azoles and allylamines inhibit key enzymes in the ergosterol biosynthetic pathway; and echinocandins block the synthesis of beta-glucan, leading to cell wall instability and lysis [10, 15]. Because these components are either absent or significantly different in human cells, they allow for the targeted treatment of a wide range of infections, from superficial mycoses to life-threatening systemic candidiasis and aspergillosis [3, 12]. However, clinical challenges such as nephrotoxicity, hepatotoxicity, and the rising prevalence of drug-resistant strains continue to drive the development of novel agents targeting these cellular components [1, 10].

Other names

Yeast and fungal cell membranesFungal cell envelopeFungal plasma membraneFungal cell wallErgosterol-rich membraneBeta-glucan-rich cell wall

Antifungal agents target these components through several distinct mechanisms: polyenes (e.g., Amphotericin B) bind directly to ergosterol in the cell membrane to form pores that cause ion leakage and cell death; azoles (e.g., Fluconazole) and allylamines (e.g., Terbinafine) inhibit enzymes such as lanosterol 14-alpha-demethylase and squalene epoxidase to block ergosterol biosynthesis; and echinocandins (e.g., Caspofungin) and triterpenoids (e.g., Ibrexafungerp) inhibit beta-(1,3)-D-glucan synthase to disrupt the structural integrity of the fungal cell wall [1, 3, 10, 15].